Sudden cardiac death due to risperidone therapy in a patient with possible hypertrophic cardiomyopathy [1]

Annals of Pharmacotherapy

Volumn 39, Issue 5, 2005, Pages 973-

  Marti, Vicens ^a  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BIPERIDEN; HALOPERIDOL; RISPERIDONE;

ADULT; ANGIOCARDIOGRAPHY; CASE REPORT; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; EXERCISE TEST; HOLTER MONITORING; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; LETTER; MALE; MITRAL VALVE REGURGITATION; PRIORITY JOURNAL; RESUSCITATION; SCHIZOPHRENIA; SIDE EFFECT; SUDDEN DEATH;

ADULT; ANTIPSYCHOTIC AGENTS; CARDIOMYOPATHY, HYPERTROPHIC; DEATH, SUDDEN, CARDIAC; HUMANS; MALE; RISPERIDONE;

EID: 17644367857     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1E539     Document Type: Letter

References (5)

1. Lo Vecchio F, Hamilton RJ, Hoffman RJ. Risperidone overdose. Am J Emerg Med 1996;14:95-6.
2. Haddad PM, Anderson IM. Antipsychotic-related QTc prolongation, torsade de pointes and sudden death. Drugs 2002;11:1649-71.
3. Klues HG, Maron BJ, Dollar AL, Roberts WC. Diversity of structural mitral valve alterations in hypertrophic cardiomyopathy. Circulation 1992;85:1651-60.
4. Hennessy S, Bilker WB, Knauss JS, Margolis DJ, Kimmel SE, Reynolds RF, et al. Cardiac arrest and ventricular arrhythmia in patients taking antipsychotic drugs: cohort study using administrative data. BMJ 2002;325:1070-5.
5. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.